← Home / IDEXX LABORATORIES INC /DE (IDXX)
Stock Analysis
IDEXX LABORATORIES INC /DE (IDXX)
IDXX
IDXX · Healthcare • Diagnostics
559.07 +0.05%
Track IDXX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IDXX price is:
52W Range Position
14%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 23:56 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 559.26. Holding above 557.10 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Positive
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
557.10
↗
Break Above
Confirmation improves above resistance.
559.26
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 557.10
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
5
●
Financial Results
HIGH
IDEXX Laboratories Announces First
Quarter Results ▪ Achieves first quarter revenue growth of 14% as reported and 11% organic, and CAG Diagnostics recurring revenue growth of 14% as reported and 11% organic.
8-K Filing • SEC EDGAR
What's Driving IDXX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 559.26 for confirmation and 557.10 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 535.73 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 37
Trigger
568.16
Invalidation
568.16
RSI(14)
50.9
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 535.73 and resistance around 559.26. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.
Price Chart
IDXX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Quality
Quality premium
The stock trades with a premium profile supported by profitability and quality metrics.
Market Cap
$44.3B
Company size
EV
$44.7B
Debt-adjusted value
P/E
40.4
Premium
P/S
10.0
Balanced
P/B
28.5
Very high
EV/Sales
10.1
Premium
EV/EBIT
31.8
Reasonable
P/FCF
40.9
Premium
FCF Yield
2.45%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Improving
●
Profitability
Positive
≈
Cash Flow
Healthy
⚖
Balance Sheet
Manageable
💵 Revenue
1.14B
↗ Improving
📈 Net Income
278.45M
↗ Positive
🧮 EPS (Basic)
0.60
↗ Positive
IDEXX LABORATORIES INC /DE
Healthcare • Diagnostics
Related Opportunities